ABCD² Score: Clinical Guide

Overview

The ABCD² score is a seven-point clinical prediction score developed to estimate early stroke risk after a transient ischaemic attack. Its components are Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes.

Clinical Significance

A higher score was associated with a greater early stroke risk in the original derivation and validation cohorts. However, a low score does not reliably exclude clinically important vascular disease, stroke mimics or patients who still require urgent investigation.

When to Use

• Use only after a clinician has assessed the presentation as a suspected transient ischaemic attack.
• Use as supplementary risk information within an established local TIA pathway.
• Do not use the score as a diagnostic test for TIA.
• Do not use it to determine whether urgent specialist assessment is required.

How It Is Calculated

• Age 60 years or older: 1 point.
• Initial systolic blood pressure at least 140 mmHg or diastolic blood pressure at least 90 mmHg: 1 point.
• Unilateral weakness: 2 points.
• Speech disturbance without weakness: 1 point.
• Other clinical features: 0 points.
• Symptoms lasting 60 minutes or longer: 2 points.
• Symptoms lasting 10 to 59 minutes: 1 point.
• Symptoms lasting less than 10 minutes: 0 points.
• Diabetes mellitus: 1 point.
• Total score range: 0 to 7.

Interpretation

• 0–3 points: lower score group.
• 4–5 points: intermediate score group.
• 6–7 points: higher score group.
• These group labels describe the numerical score only and must not be used to delay assessment or treatment.

Worked Example

A 67-year-old patient with an initial blood pressure of 152/94 mmHg, unilateral weakness lasting 25 minutes and no diabetes scores 1 point for age, 1 for blood pressure, 2 for weakness, 1 for duration and 0 for diabetes, giving a total ABCD² score of 5.

Patient Considerations

• The score does not include brain imaging, carotid imaging, cardiac assessment or recurrent events.
• Posterior circulation symptoms and atypical presentations may not be adequately represented by the score.
• Clinical assessment should consider alternative diagnoses, ongoing neurological deficits and features suggesting established stroke.

Limitations

• ABCD² has limited sensitivity when used alone to identify all patients at high early stroke risk.
• Patients with low scores may still have symptomatic carotid stenosis, atrial fibrillation or acute infarction.
• The score was developed for risk prediction, not for confirming or excluding the diagnosis of TIA.
• Current NICE guidance advises against using ABCD² to determine referral urgency after suspected or confirmed TIA.

Clinical Pearls

• Record the individual components as well as the total score.
• Treat persistent neurological symptoms as possible stroke rather than TIA.
• Follow the current local stroke and TIA pathway regardless of the calculated category.
• Urgent imaging and specialist assessment may identify high-risk pathology not represented in the score.

Common Mistakes

• Using the score before establishing that the episode is clinically compatible with TIA.
• Counting speech disturbance and unilateral weakness together; weakness takes the two-point clinical-feature allocation.
• Using the score to reassure a patient or postpone referral.
• Interpreting a low numerical score as a low clinical priority.

Evidence Base

The combined ABCD² score was validated and refined by Johnston and colleagues using cohorts from California and Oxford. Subsequent guidelines have emphasised that prediction scores should not be used alone for triage because clinically important disease can occur across all score groups.

References

1. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283–292. — Original ABCD² validation and refinement study.
2. NICE. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. NG128. — Advises against using ABCD² to determine subsequent stroke risk or referral urgency.
3. Fonseca AC, Merwick Á, Dennis M, et al. European Stroke Organisation guidelines on management of transient ischaemic attack. Eur Stroke J. 2021;6(2):CLXIII–CLXXXVI. — Recommends against using prediction tools alone for triage and treatment decisions.
4. Amin HP, Madsen TE, Bravata DM, et al. Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting. Stroke. 2023;54:e109–e121. — Scientific statement on comprehensive TIA assessment and risk reduction.